Sylvain Mareschal, Ph.D.
Bioinformatics engineer
June 19, 2013 at 16:00
Jardin et al, ICML 2013
Related entries:
Oral communication
12th International Conference on Malignant Lymphoma (Lugano, Switzerland)
Session 1 - Biology of Diffuse Large B-Cell Lymphoma (#011)

Integrated analysis identified deletion of CDKN2A as the most frequent and unique genomic abnormality in Diffuse Large B-Cell Lymphoma (DLBCL) with strong pronostic value not overcome by a dose-intensive immunochemotherapy. A LYSA study.

Fabrice Jardin

Scientific program on ICML website